Jennifer Couzin. Show Affiliations »
Abstract
Mesh： See more » Antibodies, Antinuclear/analysisAntibodies, Antinuclear/bloodAntibodies, Antinuclear/immunologyAntibody AffinityClinical Trials, Phase III as TopicClinical Trials, Phase IV as TopicDrug ApprovalDrug IndustryHumansLupus Erythematosus, Systemic/drug therapyLupus Nephritis/drug therapyOligonucleotides/adverse effectsOligonucleotides/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances： See more » Antibodies, AntinuclearOligonucleotidesabetimus
Year: 2005 PMID： 15705822 DOI： 10.1126/science.307.5711.835
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728